Fecal Occult Testing Market Insights Growth from 2025-2031

Posté 2026-02-06 17:29:53

7KB

Market Overview

Fecal Occult Testing (FOBT) refers to the segment of diagnostic testing that detects hidden (occult) blood in the stool, which is often an early sign of colorectal cancer or gastrointestinal disorders. FOBTs are widely used in routine screenings, especially among older adults or individuals with a family history of colorectal conditions. The FOBT market includes two main types of tests: guaiac-based fecal occult blood tests (gFOBT) and fecal immunochemical tests (FIT), with FIT being more commonly used due to its higher sensitivity and specificity. The growing emphasis on early cancer detection, increasing public health awareness, and government screening initiatives are accelerating the adoption of FOBT worldwide.

Key Players

Abbott Laboratories, Beckman Coulter Inc, Biohit Oyj, BioRad Laboratories Inc, Cardinal Health Inc, Eiken Chemical Co Ltd, Epigenomics AG, Exact Sciences Corporation, F HoffmannLa Roche Ltd, Fujirebio, Helena Laboratories, Hemosure Inc, Immunostics Inc, Kyowa Medex Co Ltd, Quidel Corporation, Quest Diagnostics, Randox Laboratories Ltd, Siemens Healthineers, Sysmex Corporation, TaiDoc Technology Corporation, Thermo Fisher Scientific Inc, VEDA LAB, Vela Diagnostics, VolitionRx Limited, Zymo Research

Sample link - https://www.trendbridgeinsights.com/industry-report/fecal-occult-testing-market

Market segmentation:

Product Type

· Guaiac Fecal Occult Blood Test gFOBT

· Immunochemical Fecal Occult Blood Test iFOBT

· Fecal DNA Testing

· Others

Test Method

· Laboratorybased Tests

· PointofCare Tests

· Fecal Immunochemical Tests FIT

· Guaiacbased Tests

· Others

Application

· Colorectal Cancer Screening

· Gastric Cancer Screening

· Other Gastrointestinal Conditions

· NonGastrointestinal Diseases

End User

· Hospitals

· Diagnostic Laboratories

· Clinics

· Research Institutes

· Others

Mega Trend Connect:

This report offers deep insights into how mega trends such as digitalization, precision medicine, data-driven care delivery, and regulatory evolution are transforming medical devices. It further examines the impact of advanced technologies, platform-based models, automation, and interoperability across products and services within this segment. The report assesses regulatory complexity, adoption readiness, cost pressures, and ecosystem maturity shaping global market development.

Global Trade Outlook:

Global trade in medical devices is increasingly shaped by regulatory stringency, localization mandates, data sovereignty requirements, and public health policy priorities. Cross-border scalability is constrained by approval timelines, compliance variation, and infrastructure readiness, driving regionalized production, partnerships, and delivery models. Market access and competitiveness now depend on regulatory agility, localized execution, and compliance-by-design strategies.

Region Analysis :

North America leads the FOBT market due to strong colorectal cancer screening programs and high awareness, with the U.S. driving adoption through national guidelines. Europe follows with mandatory screening initiatives in the UK, Germany and France. Asia-Pacific grows fastest as China, Japan and India expand prevention programs, while Latin America and MEA show steady but limited adoption.

Recent development :

In March 2025, QuidelOrtho Corporation introduced its next generation fecal immunochemical test for colorectal screening in Europe for high-throughput laboratory environments. The new assay promises faster turnaround times and better sensitivity compared to conventional FIT kits.

FAQ:

1 . What is the Forecasted market size & CAGR of the Fecal Occult Testing Market ?

The global FOBT market size was USD 2.0 billion in 2024 and is forecast to reach USD 3.1 billion in 2031, growing at a CAGR of 8.8% during the forecast period.

2. Who are the leading manufacturers and suppliers in the Fecal Occult Testing Market ?

Abbott Laboratories, Beckman Coulter Inc, Biohit Oyj, BioRad Laboratories Inc, Cardinal Health Inc, Eiken Chemical Co Ltd, Epigenomics AG, Exact Sciences Corporation, F HoffmannLa Roche Ltd

3. What are the upcoming trends of Fecal Occult Testing Market in the globe?

At-Home Screening Kits Experience Increasing Popularity: The COVID-19 pandemic has accelerated the adoption of at-home fecal occult testing kits. The home-based stool testing kits enable people to gather their samples in private before sending them to labs for analysis which boosts regular screening participation and reaches more people in areas with limited access.

4. Which is the largest regional market for Fecal Occult Testing Market ?

North America leads the market because of its high healthcare awareness combined with its widespread screening programs for colorectal cancer and its government support for preventive healthcare initiatives.

About US: